S'abonner

Are perioperative bundles associated with reduced postoperative morbidity in women undergoing benign hysterectomy? Retrospective cohort analysis of 16,286 cases in Michigan - 27/09/17

Doi : 10.1016/j.ajog.2016.12.173 
John A. Harris, MD, MSc a, , Anne G. Sammarco, MD, MPH a, Carolyn W. Swenson, MD a, Shitanshu Uppal, MD a, Neil Kamdar, MA a, Darrel Campbell, MD b, Sarah Evilsizer, RN c, John O. DeLancey, MD a, Daniel M. Morgan, MD a
a Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI 
b Department of Surgery, University of Michigan, Ann Arbor, MI 
c Michigan Surgical Quality Collaborative, Ann Arbor, MI 

Corresponding author: John A, Harris, MD.

Abstract

Background

Healthcare teams that frequently follow a bundle of evidence-based processes provide care with lower rates of morbidity. Few process bundles to improve surgical outcomes in hysterectomy have been identified.

Objective

The purpose of this study was to investigate whether a bundle of 4 perioperative care processes is associated with fewer postoperative complications and readmissions for hysterectomies in the Michigan Surgical Quality Collaborative.

Study Design

A bundle of perioperative care process goals was developed retrospectively with 30-day peri- and postoperative outcome data from the Hysterectomy Initiative in Michigan Surgical Quality Collaborative. All benign hysterectomies that had been performed between January 2013 and January 2015 were included. Based on evidence of lower complication rates after benign hysterectomy, the following processes were considered to be the “bundle”: use of guideline-appropriate preoperative antibiotics, a minimally invasive surgical approach, operative duration <120 minutes, and avoidance of intraoperative hemostatic agent use. Each process was considered present or absent, and the number of processes was summed for a bundle score that ranged from 0–4. Cases with a score of zero were excluded. Outcomes measured were rates of complications (any and major) and hospital readmissions, all within 30 days of surgery. Postoperative events that were considered a “major complication” included acute renal failure, cardiac arrest that required cardiopulmonary resuscitation, central line infection, cerebral vascular accident, death, deep vein thrombosis, intestinal obstruction, myocardial infarction, pelvic abscess, pulmonary embolism, rectovaginal fistula, sepsis, surgical site infection (deep and organ-space), unplanned intubation, ureteral obstruction, and ureterovaginal and vesicovaginal fistula. The outcome “any complication” included all those events already described in addition to blood transfusion within 72 hours of surgery, urinary tract infection, and superficial surgical site infection. Outcomes were adjusted for patient demographics, surgical factors, and hospital-level clustering effects.

Results

There were 16,286 benign hysterectomies available for analysis. Among all hysterectomies that were reviewed, 33.6% met criteria for all bundle processes; however, there was wide variation in the rate among the 56 hospitals in the study sample with 9.1% of cases at the lowest quartile and 60.4% at the highest quartile of hospitals that met criteria for all bundle processes. Overall, the rate of any complication was 6.8% and of any major complication was 2.3%. The rate of hospital readmissions was 3.6%. After adjustment for confounders, in cases in which all bundle criterion were met compared with cases in which all bundle criterion were not met, the rate of any complications increased from 4.3–7.8% (P<.001); major complications increased from 1.7–2.6% (P<.001), and readmissions increased from 2.6–4.1% (P<.001). After adjustment for confounders, hospitals with greater rates of meeting all 4 criteria were associated significantly with lower hospital-level rates of postoperative complications (P<.001) and readmissions (P<.001).

Conclusions

This multiinstitutional evaluation reveals that reduced morbidity and readmission are associated with rates of bundle compliance. The proposed bundle is a surgical goal, which is not possible in every case, and there is significant variation in the proportion of cases meeting all 4 bundle processes in Michigan hospitals. Implementation of evidence-based process bundles at a healthcare system level are worthy of prospective study to determine whether improvements in patient outcomes are possible.

Le texte complet de cet article est disponible en PDF.

Key words : bundle, hysterectomy, morbidity


Plan


 Dr Harris is currently affiliated with the University of Pittsburgh.
 The Michigan Surgical Quality Collaborative database is funded by Blue Cross and Blue Shield of Michigan/Blue Care Network. Investigator support for J.A.H. included the Robert Wood Johnson Foundation as a Clinical Scholar at the University of Michigan and National Institute of Child Health and Human Development WRHR Career Development Award K12 HD063087 at the University of Pittsburgh (The Robert Wood Johnson Foundation was not directly involved in study design, data acquisition and interpretation, manuscript preparation or review. Any opinions expressed herein do not necessarily reflect the opinions of the Robert Wood Johnson Foundation.) Investigator support for C.W.S. was provided by the National Institute of Child Health and Human Development WRHR Career Development Award K12 HD065257. Investigator support for J.O.D. was provided by Office of Research on Women’s Health P50 HD044406 and the National Institute of Child Health and Human Development R01 HD038665. D.M.M. and S.E. receive salary support from the Michigan Surgical Quality Collaborative.
 The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
 The authors report no conflict of interest.
 Cite this article as: Harris JA, Sammarco AG, Swenson CW, et al. Are perioperative bundles associated with reduced postoperative morbidity in women undergoing benign hysterectomy? Retrospective cohort analysis of 16,286 cases in Michigan. Am J Obstet Gynecol 2017;216:502.e1-11.


© 2017  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 216 - N° 5

P. 502.e1-502.e11 - mai 2017 Retour au numéro
Article précédent Article précédent
  • Periprocedural outcomes comparing fibroid embolization and focused ultrasound: a randomized controlled trial and comprehensive cohort analysis
  • Emily P. Barnard, Ahmed M. AbdElmagied, Lisa E. Vaughan, Amy L. Weaver, Shannon K. Laughlin-Tommaso, Gina K. Hesley, David A. Woodrum, Vanessa L. Jacoby, Maureen P. Kohi, Thomas M. Price, Angel Nieves, Michael J. Miller, Bijan J. Borah, Krzysztof R. Gorny, Phyllis C. Leppert, Lisa G. Peterson, Elizabeth A. Stewart
| Article suivant Article suivant
  • Racial/ethnic differences in contraceptive preferences, beliefs, and self-efficacy among women veterans
  • Lisa S. Callegari, Xinhua Zhao, Eleanor Bimla Schwarz, Elian Rosenfeld, Maria K. Mor, Sonya Borrero

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.